7101 604545 Zenshine Pharmaceuticals Meets Endpoint of Influenza Studyの詳細情報
Zenshine Pharmaceuticals Meets Endpoint of Influenza Study。PA-E18G substitution in influenza A virus confers resistance to ZX。Efficacy and safety of ZX-7101A, an inhibitor of influenza cap。よろしくお願いいたします。Vacuum Power Brake Booster - 54-71056。